Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
NAPA Duckhorn Portfolio Inc
NDACU Nightdragon Acquisition Corp
EMPYF Empress Royalty Corp
CGC Canopy Growth Corp
FMCB Farmers & Merchants Bancorp
GM General Motors Co
CBMB CBM Bancorp Inc
SCHW Charles Schwab Corp
WSC Willscot Mobile Mini Holdings Corp
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company's commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and rare diseases. It is also engaged in the research, development of monoclonal antibodies, which consists of Dupixent, Kevzara, and itepekimab. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, Kevzara (sarilumab) Solution for Subcutaneous Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion.

Closing Price
$635.16
Day's Change
1.16 (0.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
641.79
Day's Low
623.12
Volume
(Average)
Volume:
650,359

10-day average volume:
659,410
650,359
  • Prev Close
    634.00
  • Today's Open
    637.77
  • Day's Range
    623.12-641.79
  • Avg Vol (10-day)
    659.4K
  • Last (time)
    4:00p ET 12/03/21
  • Last (size)
    4
  • 52-Wk Range
    441.00 - 686.62
    LowHigh
  • (03/04/21 - 09/03/21)
    7.49%
  • 25.7%
  • Market Cap
    68.3B
  • Shares Outstanding
    107.5M
  • 62.64
  • 10.12x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 85.51
  • (% of float 11/15/21)
    1.56

Latest News

December 03, 2021
5:19 pm ET
MarketWatch
10:00 am ET
PR Newswire
December 02, 2021
5:19 pm ET
MarketWatch
December 01, 2021
5:19 pm ET
MarketWatch
6:46 am ET
MarketWatch
November 30, 2021
5:19 pm ET
MarketWatch
8:45 am ET
PR Newswire
8:45 am ET
PR Newswire
6:26 am ET
MarketWatch
November 29, 2021
5:19 pm ET
MarketWatch
3:08 pm ET
MarketWatch
November 24, 2021
5:19 pm ET
MarketWatch
November 23, 2021
5:19 pm ET
MarketWatch
November 22, 2021
5:19 pm ET
MarketWatch
November 19, 2021
5:19 pm ET
MarketWatch
November 18, 2021
5:19 pm ET
MarketWatch
November 17, 2021
5:19 pm ET
MarketWatch
November 16, 2021
5:19 pm ET
MarketWatch
4:15 pm ET
PR Newswire
November 15, 2021
5:19 pm ET
MarketWatch
7:00 am ET
PR Newswire
November 12, 2021
5:19 pm ET
MarketWatch
4:18 pm ET
MarketWatch
4:11 pm ET
PR Newswire
10:38 am ET
MarketWatch
10:20 am ET
PR Newswire
November 11, 2021
5:19 pm ET
MarketWatch
11:03 am ET
PR Newswire
November 10, 2021
5:19 pm ET
MarketWatch
November 09, 2021
5:19 pm ET
MarketWatch
6:18 am ET
MarketWatch
November 08, 2021
5:19 pm ET
MarketWatch
7:41 am ET
MarketWatch
7:04 am ET
MarketWatch
7:04 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.